Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: A seven-year experience

Eurosurveillance

Volumn 17, Issue 30, 2012, Pages

  Fournier, S ^a   Brossier, F ^b   Fortineau, N ^c   Gillaizeau, F ^d   Akpabie, A ^e   Aubry, A ^f   Barbut, F ^g   Chedhomme, F X ^h   Kassis Chikhani, N ⁱ   Lucet, J C ^j   Robert, J ^b   Seytre, D ^k   Simon, I ^l   Vanjak, D ^m   Zahar, J R ⁿ   Brun Buisson, C ^o   Jarlier, V ^a,b  

^a Hôpital Pitié Salpêtrière ^*

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BICÊTRE HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e Emile Roux Hospital AP HP   (France)

^f HÔPITAL CHARLES FOIX   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h 75005   (France)

ⁱ HÔPITAL PAUL BROUSSE   (France)

^j BICHAT HOSPITAL   (France)

^k AVICENNE HOSPITAL   (France)

^l Versailles Saint Quentin en Yvelines University   (France)

^m BEAUJON HOSPITAL   (France)

ⁿ HÔPITAL NECKER ENFANTS MALADES   (France)

^o HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CONTROL STRATEGY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIC; FRANCE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; MULTIHOSPITAL SYSTEM; PATIENT CARE; PHYLOGENETIC TREE; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; SCREENING TEST; TEACHING HOSPITAL; TIME SERIES ANALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84866445783     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470-85.
2. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother. 2004;48(1):275-80.
3. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2009. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2010. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispFo rm.aspx?ID=580.
4. McGowan JE. Debate-guidelines for control of glycopeptideresistant enterococci (GRE) have not yet worked. J Hosp Infect. 2004;57(4):281-4.
5. Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001;344(19):1427-33.
6. Fortineau N, Bourdon N, Leclercq R, Vachée A, Delarbre J-M, Maugat S, et al. Low carriage of vancomycin-resistant enterococci in the digestive tract of French hospitalised patients: a nationwide prospective study in 2006. J Hosp Infect. 2011;77(2):179-81.
7. Naas T, Fortineau N, Snanoudj R, Spicq C, Durrbach A, Nordmann P. First nosocomial outbreak of vancomycinresistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J Clin Microbiol. 2005;43(8):3642-9.
8. Lesens O, Mihaila L, Robin F, Baud O, Romaszko JP, Tourniac O, et al. Outbreak of colonization and infection with vancomycinresistant Enterococcus faecium in a French university hospital. Infect Control Hosp Epidemiol. 2006;27(9):984-6.
9. Lucet JC, Armand-Lefevre L, Laurichesse JJ, Macrez A, Papy E, Ruimy R, et al. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. J Hosp Infect. 2007;67(1):42-8.
10. Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med. 2010 22;170(6):552-9.
11. Astagneau P, Costa Y, Legrand P, Lucet J, Marty L, Prieur B. Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques. [Control of the spread of multiple-antibiotic resistant bacteria]. Paris: Ministère de l'Emploi et de la Solidarité, Secrétariat d'Etat à la Santé et à l'Action Sociale, Comité Technique National des Infections Nosocomiales;1999. French.
12. Brown DF, Walpole E. Evaluation of selective and enrichment media for isolation of glycopeptide-resistant enterococci from faecal specimens. J Antimicrob Chemother. 2003;51(2):289-96.
13. Eigner U, Fahr A, Weizenegger M, Witte W. Evaluation of a new molecular system for simultaneous identification of four Enterococcus species and their glycopeptide resistance genotypes. J Clin Microbiol. 2005;43(6):2920-2.
14. Société Française de Microbiologie. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2006. [Statement 2006]. Paris: 2006. French. Available from: http://www.sfm-microbiologie.org/UserFiles/file/CASFM/casfm_2006.pdf.
15. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol. 1990;28(9):2059-63.
16. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-9.
17. Morrison D, Woodford N, Barrett SP, Sisson P, Cookson BD. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J. Clin. Microbiol. 1999;37(4):1084-91.
18. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309.
19. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasiexperimental studies in infectious diseases. Clin Infect Dis. 2004;38(11):1586-91.
20. Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol. 2004;25(5):384-90.
21. Kurup A, Chlebicki MP, Ling ML, Koh TH, Tan KY, Lee LC, et al. Control of a hospital-wide vancomycin-resistant Enterococci outbreak. Am J Infect Control. 2008;36(3):206-11.
22. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158(10):1127-32.
23. Ridwan B, Mascini E, van Der Reijden N, Verhoef J, Bonten M. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? BMJ. 2002;324(7338):666-8.
24. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis. 2003;37(3):326-32.
25. Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2002;23(4):207-11.
26. Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D, Sengelin C, et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill. 2010;15(46). Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19713
27. Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis-Chikhani N, Boytchev I, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill. 2010;15(48). Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19734
28. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect. 2010;16(2):102-11.